Crossref

1. HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives

- Laura Maffei

- Francesco Sorrentino

- Patrizia Caprari

- Gloria Taliani

- Sara Massimi

- Roberta Risoluti

- Stefano Materazzi

2. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment

- Hani Alothaid

- Mohammed S. K. Aldughaim

- Karim El Bakkouri

- Sufana AlMashhadi

- Ahmed A. Al-Qahtani

3. Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major

- Aabha Nagral

- Smita Sawant

- Nishtha Nagral

- Pathik Parikh

- Priya Malde

- Rashid Merchant

4. Burden of Hepatitis C on Patients with Thalassemia

- Zahra Sepehri

- Seyed Moayed Alavian

5. Burden of Hepatitis C on Patients with Thalassemia

- Zahra Sepehri

- Seyed Moayed Alavian

6. Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis

- Chao-Fu Yang

- Balraj Gopula

- Jian-Jong Liang

- Jin-Kun Li

- Si-Yu Chen

- Yi-Ling Lee

- Ching S. Chen

- Yi-Ling Lin

7. The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C

- Po-Cheng Liang

- Pei-Chin Lin

- Ching-I. Huang

- Chung-Feng Huang

- Ming-Lun Yeh

- Yu-Sheng Zeng

- Wan-Yi Hsu

- Ming-Yen Hsieh

- Zu-Yau Lin

- Shinn-Cherng Chen

- Jee-Fu Huang

- Chia-Yen Dai

- Wan-Long Chuang

- Shyh-Shin Chiou

- Ming-Lung Yu

8. Hepatoprotective effects of metformin in hepatitis C virus‐infected adolescents with beta thalassaemia major

- Ali Talebi

- Mona Kargar